There were two different stories for InMode (NASDAQ: INMD) in 2022. In the first half of the year, the medical device stock plunged 68%. However, in the second half, InMode roared back, with its ...

Individual investors who want help picking stocks have more than a few options to choose from, including the recommendations of Wall Street analysts. Analysts usually have considerably more resources ...

InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

These projections put the company in a fairly good position and indicate that on the low side InMode is near fair value, but on the high side has a lot of potential. Showing these various cases, ...

Typically, I can find a problem for a company or at least something the market is concerned about. Over extended periods of time, these concerns are usually manifested around earnings reports. However ...

Discover why InMode Ltd. looks undervalued: strong free cash flow, buybacks, and global growth catalysts—get the latest ...

InMode announced governance and leadership changes in May 2026, appointing corporate law and finance expert Dr. Shlomo Nass as chairman of the board and independent Class II director, effective May 19 ...